跳到正文
原文
pharmalot· @pharmalot · X·· 7 天前AI 评分28
AI 导读

分析发现,药企在向中低收入国家提供药品可及性方面表现“参差不齐”。https://www.statnews.com/pharmalot/2026/11/10/access-to-key-drugs-mixed-in-poor-countries-cancer-diabetes/ #pharma #biotech #medicine #affordability #cancer #diabetes #access #Novartis $NVS

正文

Pharma is a ‘mixed bag’ when providing drug access to low- and middle-income countries, analysis finds.. https://www.statnews.com/pharmalot/2026/11/10/access-to-key-drugs-mixed-in-poor-countries-cancer-diabetes/ #pharma #biotech #medicine #affordability #cancer #diabetes #access #Novartis $NVS

来源:pharmalot · x.com